6533b829fe1ef96bd128a5e7

RESEARCH PRODUCT

COVID-19 and diabetes management: What should be considered?

Manfredi RizzoAnca Pantea StoianAntonio Ceriello

subject

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Clinical effectivenessbusiness.industryEndocrinology Diabetes and MetabolismSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cardiovascular disease COVID-19 Diabetes DPP4 GLP-1RA Hydroxychloroquine Pioglitazone SGLT-2General Medicinemedicine.diseaseEndocrinologyDiabetes managementDiabetes mellitusInternal MedicinemedicineSodium-Glucose Cotransporter 2 InhibitorIntensive care medicinebusinessPioglitazonemedicine.drug
yearjournalcountryeditionlanguage
2020-05-01Diabetes research and clinical practice
10.1016/j.diabres.2020.108151https://pubmed.ncbi.nlm.nih.gov/32305399